Annalisa Jenkins

Functions as a College/University

Operates as a biotechnology company that develops drugs for reproductive and metabolism

Operates as non-profit community for women leaders of diverse achievement

Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders

Operates medical diagnostic laboratories

A government commission

Operates as a organization to help women entrepreneurs and executives

Develops cell immunotherapies for treatment of solid and hematological malignancies

Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Organizes healthcare conferences and other events

Provides clinical testing services for cancer detection

Functions as a College/University

Provides technology solutions for diagnosing and staging liver disease

Develops novel treatments for rare diseases

Operates genomes project in research and health care for patients with cancer and rare diseases and their families

Provides biopharmaceutical research services

Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders

Operates as a biopharmaceutical company

Engages in research that leverages talent across the divides of gender,generation, geography, and culture and to create a community

Develops device to monitor and understand the biological processes associated with heart disease

Focuses on designing, engineering and developing targeted protein therapeutics

Develops cancer immunotherapy

MedCity Ltd. is a central organization dedicated to accelerating innovation, investment, and growth within the life sciences sector. The private company is based in Canterbury, UK. It supports a broad range of life sciences companies—including biotech, medtech, diagnostics, digital health, and advanced therapies—by providing expert guidance, tailored business growth services, and access to a network of investors, academia, industry, and the NHS. MedCity runs programs such as Grow, Health Accelerator for Social Enterprise, TechBio Boost, Collaborate to Innovate, and the Investment Hub, which offer accelerators, seed funding, pitch events, mentorship, and strategic partnerships to help SMEs scale, secure investment, and expand internationally. The organization facilitates connections between SMEs and a network of over 400 angel and venture capital investors, and offers a free brokerage service to help companies find R&D and manufacturing lab space across key life science clusters. MedCity provides resources including setup guides for companies relocating or investing, market intelligence reports, sector analyses, and updates on funding and regulatory developments. Through events and newsletters, MedCity keeps stakeholders informed and engaged, emphasizing collaboration across the ecosystem to foster innovation and raise awareness of the region as a life sciences hub.

Develops liposomal iNKT agonists

Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose

Provides cancer detection and diagnosis services

Develops novel therapeutics

Manufactures pharmaceuticals

Provides drug and clinical development services for life sciences companies

Develops microbiome-targeted therapies for inflammatory skin conditions

Provides statistical analyses and advanced insights to the healthcare industry

Develops therapies and drugs for the treatment of mental health and neurocognitive conditions

Provides business and private economic services

Functions as an investment holding company

Manufactures capsules that controls sweating

RYSE Asset Management invests in companies located across the globe. The firm focuses on the healthtech sector. It participates in seed and early stage capital requirements.

Operates as a medical diagnostics IP company

Conduit Connect invests in companies located in the United Kingdom. The firm targets companies operating in the fields of information technology, health care and financial services. It provides financing for seed and early stage capital transactions.

Develops digital technology platform that help clinicians to provide better care for patients with liver disease